Xenotransplantation of transgenic pig olfactory ensheathing cells	1
Xenotransplantation	1
transgenic pig olfactory ensheathing cells	24
axonal regeneration	76
rat spinal cord	99
Abstract	116
we	130
transplantation of olfactory ensheathing cells	142
transplantation	142
olfactory ensheathing cells	161
OECs	190
Schwann cells	199
transgenic pigs	226
the human complement inhibitory protein , CD59 -LRB- hCD59 -RRB-	253
the human complement inhibitory protein	253
CD59	294
hCD59	300
dorsal column lesions of the spinal cord of the immunosuppressed rat	324
dorsal column lesions	324
the spinal cord of the immunosuppressed rat	349
the spinal cord	349
the immunosuppressed rat	368
axonal regeneration	403
Non-transplanted lesion-controlled rats	424
no impulse conduction	474
the transection site	503
animals	536
transgenic pig OECs or Schwann cells	554
impulse conduction	591
the lesion site	641
more than a centimeter	661
Cell labeling	685
the donor cells	714
the denervated host tract	744
the	744
host tract	759
Conduction velocity measurements	771
the regenerated axons	816
impulses	848
normal axons	869
morphological analysis	886
the axons	910
a peripheral pattern of myelin expected from the donor cell type	951
a peripheral pattern	951
myelin expected from the donor cell type	975
myelin	975
the donor cell type	996
These results	1017
xenotranplantation	1045
myelin-forming cells	1067
pigs genetically altered to reduce the hyperacute response in humans	1093
pigs	1093
the hyperacute response	1128
humans	1155
elongative axonal regeneration and remyelination	1181
impulse conduction	1242
the transected spinal cord	1268
There	1297
much interest	1306
the potential	1323
xenotransplantation	1340
genetically engineered pig cells as a source for human cell therapies1 ,2	1363
genetically engineered pig cells	1363
a source for human cell therapies1 ,2	1399
a source	1399
human cell therapies1 ,2	1412
human cell therapies1	1412
,2	1433
primate tissues	1444
pigs	1461
an ethically acceptable source of cells	1493
an ethically acceptable source	1493
cells	1527
relatively large quantities of pig cells	1544
relatively large quantities	1544
pig cells	1575
potential cell therapies	1606
An important obstacle with xenotranplantation	1632
An important obstacle	1632
xenotranplantation	1659
the problem	1681
natural antibody reactivity and subsequent complement activation	1696
complement-mediated cell lysis	1775
One approach to address this problem	1807
One approach	1807
this problem	1831
engineer pig cells	1856
a human complement inhibitory protein -LRB- e.g. , hCD59 -RRB-	1886
a human complement inhibitory protein	1886
e.g. , hCD59	1925
e.g.	1925
hCD59	1931
the present study	1942
we	1960
transgenic pigs engineered to express hCD59	1980
transgenic pigs	1980
hCD59	2018
this protein	2042
olfactory ensheathing cells -LRB- OECs -RRB- and Schwann cells	2058
olfactory ensheathing cells -LRB- OECs -RRB-	2058
olfactory ensheathing cells	2058
OECs	2087
Schwann cells	2097
these cells	2121
the transected rat spinal cord	2155
they	2187
axonal regeneration	2203
new	2229
conduction	2252
the injured spinal cord	2266
rat models	2294
transplants	2306
OECs	2330
ablated corticospinal tract3 , fasciculus gracilis4 , or nerve bridges	2340
ablated corticospinal tract3	2340
fasciculus gracilis4	2370
nerve bridges	2395
the spinal cord5	2412
axonal regeneration	2437
OECs	2458
several unique properties	2468
a rationale for their potential	2507
a rationale	2507
their potential	2523
CNS axonal regeneration	2550
OECs	2575
specialized cells	2584
axons	2615
the olfactory epithelium and project	2632
the peripheral nervous system	2677
the olfactory bulb of the central nervous system	2712
the olfactory bulb	2712
the central nervous system	2734
they	2762
pluripotential cells	2771
Schwann cell or astrocyte-like cell properties6	2806
Schwann cell	2806
astrocyte-like cell properties6	2822
The possibility	2855
OECs or Schwann cells , which also support CNS regeneration4 ,7 ,	2876
OECs or Schwann cells	2876
CNS regeneration4 ,7	2918
a cell therapy in humans	2956
a cell therapy	2956
humans	2974
the transected3 -- 5 and demyelinated8 ,9 spinal cord	2991
the transected3	2991
5 and demyelinated8 ,9 spinal cord	3007
5 and demyelinated8	3007
,9 spinal cord	3026
enough of the appropriate cells	3077
enough	3077
the appropriate cells	3087
Our results	3131
these genetically altered pig cells	3157
elongative regeneration of electrophysiologically functional axons	3218
elongative regeneration	3218
electrophysiologically functional axons	3245
a site of spinal cord transection in the immunosuppressed rat	3292
a site	3292
spinal cord transection in the immunosuppressed rat	3302
spinal cord transection	3302
the immunosuppressed rat	3329
These findings	3355
important prerequisites	3374
consideration	3402
these cells as candidates for xenotransplantation studies in humans	3419
these cells	3419
candidates for xenotransplantation studies in humans	3434
candidates	3434
xenotransplantation studies in humans	3449
xenotransplantation studies	3449
humans	3480
Results Figure 1 .	3489
Results	3489
Figure 1	3498
FACS analysis	3508
transgenic Schwann cells	3525
transgenic olfactory ensheathing cells -LRB- OECs -RRB-	3554
transgenic olfactory ensheathing cells	3554
OECs	3594
CD59	3611
SLA class I -LRB- A and B -RRB-	3617
SLA class I	3617
A and B	3630
A	3630
B	3636
the mAb PT85A and the goat antimouse	3657
the mAb PT85A	3657
the goat antimouse	3675
secondary control	3694
background reactivity of a non-specific antibody	3734
background reactivity	3734
a non-specific antibody	3759
CD59	3784
mAb MEM43 -LRB- A and B -RRB- and the polyclonal Ab ALP3 -LRB- C and D -RRB-	3807
mAb MEM43	3807
A and B	3818
A	3818
B	3824
the polyclonal Ab ALP3	3831
C and D	3855
C	3855
D	3861
Cells	3865
a Becton-Dickinson FACSort	3888
Figure 2 .	3917
Figure	3917
2	3924
Conduction across the transplantation zone .	3927
Conduction	3927
the transplantation zone	3945
-LRB- A -RRB- Schematic	3971
-LRB- A -RRB-	3971
Schematic	3975
transection site and positions of stimulating and recording electrodes	3993
transection site and positions	3993
electrodes	4053
Stimulating electrodes	4065
1 mm caudal	4104
the dorsal column transection site -LRB- 0 mm -RRB-	4119
the dorsal column transection site	4119
0 mm	4155
recordings	4165
1 mm intervals	4193
the lesion site	4215
-LRB- B -RRB- CAP recordings for control lesion	4232
-LRB- B -RRB- CAP recordings	4232
-LRB- B -RRB-	4232
control lesion	4255
2 -LRB- R1 -RRB- and 3 -LRB- R2 -RRB-	4279
2 -LRB- R1 -RRB-	4279
3 -LRB- R2 -RRB-	4290
mm rostral	4297
the stimulating site	4311
i.e. , 1 and 2 mm beyond the transection site , respectively	4333
i.e.	4333
1	4339
2 mm beyond the transection site , respectively	4345
2 mm	4345
the transection site , respectively	4357
the transection site	4357
dorsal columns	4405
cell transplantation	4428
Field potential recording	4454
dorsal column lesion of OEC transplant recipient	4492
dorsal column lesion	4492
OEC transplant recipient	4516
OEC transplant	4516
The peak negativities	4542
solid squares	4581
Figure 3 .	4597
Figure	4597
3	4604
Conduction properties of transplant-induced regenerated spinal cord axons .	4607
Conduction properties	4607
transplant-induced regenerated spinal cord axons	4632
-LRB- A -RRB-	4682
Comparison	4686
conduction velocity	4700
normal -LRB- non-lesioned -RRB- , dorsal column transection alone	4728
normal -LRB- non-lesioned -RRB- , dorsal column transection	4728
normal	4728
dorsal column transection	4751
Cont .	4784
transplantation of transgenic OECs or Schwann cells	4817
transplantation	4817
transgenic OECs or Schwann cells	4836
-LRB- B -RRB-	4870
no impulse conduction	4883
dorsal columns without cell transplantation , both OEC - and Schwann	4933
dorsal columns without cell transplantation , both OEC	4933
dorsal columns	4933
cell transplantation , both	4956
cell transplantation	4956
Schwann	4992
cells-transplant groups	5000
conduction	5034
the lesion	5052
distances comparable to controls	5067
distances	5067
controls	5091
-LRB- C -RRB-	5101
Both	5105
- and Schwan cell-transplant groups following high frequency	5113
- and Schwan cell-transplant groups	5113
Schwan cell-transplant	5119
Schwan	5119
high frequency	5159
non-lesioned controls	5199
-LRB- D -RRB- The refractory period from paired pulse stimulation experiments	5222
-LRB- D -RRB-	5222
The refractory period	5226
paired pulse stimulation experiments	5253
control and transplant groups	5310
Figure 4 .	5342
Figure	5342
4	5349
Presence of transgenic pig donor OECs in the recipient spinal cord .	5352
Presence	5352
transgenic pig donor OECs	5364
the recipient spinal cord	5393
OECs	5420
the fluorescent membrane marker , CFDA	5438
the fluorescent membrane marker	5438
CFDA	5471
SE	5477
the dorsal columns	5496
3 weeks	5515
cell transplantation	5529
The calibration bar	5551
20 μm	5586
Figure 5 .	5594
Figure	5594
5	5601
Ultrastructural characteristics	5604
regenerated axons following transgenic pig OEC and Schwann cells transplantation	5639
regenerated axons	5639
transgenic pig OEC and Schwann cells transplantation	5667
The tissue	5721
electrophysiological recordings	5757
Low power electron micrographs	5804
regenerated myelinated axons	5838
the fasciculus gracilis	5870
the dorsal columns	5897
OEC -LRB- A -RRB- and Schwann cell -LRB- B -RRB- transplantation	5926
OEC -LRB- A -RRB-	5926
OEC	5926
A	5931
Schwann cell -LRB- B -RRB- transplantation	5938
Schwann cell	5938
B	5952
transplantation	5955
The micrographs	5972
the lesion site	6013
the cell bodies -LRB- dorsal root ganglia -RRB- of the transected	6044
the cell bodies -LRB- dorsal root ganglia -RRB-	6044
the cell bodies	6044
dorsal root ganglia	6061
the transected	6085
sensory neurons	6110
the presence	6132
small clusters of regenerated axons following OEC transplantation	6148
small clusters	6148
regenerated axons following OEC transplantation	6166
regenerated axons	6166
OEC transplantation	6194
individual axons	6219
Schwann cell transplantation	6255
Higher power electron micrographs	6285
formation	6328
OECs -LRB- C -RRB- and Schwann cells -LRB- D -RRB-	6358
OECs -LRB- C -RRB-	6358
OECs	6358
C	6364
Schwann cells -LRB- D -RRB-	6371
Schwann cells	6371
D	6386
the presence of a basement	6408
the presence	6408
a basement	6424
D	6483
Transgenic Expression OECs and Schwann cells	6488
transgenic pigs expressing the human complement inhibitor , hCD59	6552
transgenic pigs	6552
the human complement inhibitor , hCD59	6579
the human complement inhibitor	6579
hCD59	6611
The transgenically derived OECs and Schwann cells	6618
The transgenically derived OECs	6618
Schwann cells	6654
Experimental Protocol	6698
Cells	6721
flow cytometry	6744
transgene expression	6769
The antibody , PT85A ,	6791
The antibody	6791
PT85A	6805
Swine Leukocyte Antigen -LRB- SLA -RRB- class I	6854
Swine Leukocyte Antigen -LRB- SLA -RRB-	6854
Swine Leukocyte Antigen	6854
SLA	6879
class I	6884
a positive control -LRB- Fig. 1 -RRB-	6906
a positive control	6906
Fig. 1	6926
It	6935
SLA class	6967
I expression	6977
the transgenic line	6998
a murine major histocompatibility class I promoter expression construct	7037
H2Kb-hCD59 -LRB- ref	7110
10 -RRB- .	7127
Indirect immunofluorescence analysis	7132
the transgene	7185
the cell surface	7216
both Schwann cells and OECs	7236
Schwann cells	7241
OECs	7259
the hCD59 transgenic pig -LRB- Fig. 1 -RRB-	7278
the hCD59 transgenic pig	7278
Fig. 1	7304
the concentration of endogenous SLA class I expression	7328
the concentration	7328
endogenous SLA class I expression	7349
both cell types	7400
the level of transgene expression	7426
the level	7426
transgene expression	7439
an order of magnitude	7464
an order	7464
magnitude	7476
both the OECs and Schwann cells	7494
the OECs	7499
Schwann cells	7512
This	7527
the result of integration site inactivation effects for these cell types	7541
the result	7541
integration site inactivation effects for these cell types	7555
integration site inactivation effects	7555
these cell types	7597
the absence of an enhancer element	7618
the absence	7618
an enhancer element	7633
yet unidentified in the class I gene , specific to ensheathing cells	7657
yet unidentified	7657
the class I gene , specific to ensheathing cells	7677
the class I gene	7677
specific to ensheathing cells	7695
Conduction	7726
regenerated axons	7740
the transected spinal cord Adult Wistar rats were anesthetized and laminectomies	7765
the transected spinal cord Adult	7765
Wistar rats	7798
anesthetized and laminectomies	7815
anesthetized	7815
laminectomies	7832
the dorsal column lesion	7871
described previously4	7899
Lesioned animals	7922
two cohorts	7966
a sham transplant group	7979
vehicle and a cell transplant group	8013
vehicle	8013
a cell transplant group	8025
either transgenic OECs or Schwann cells	8059
transgenic OECs	8066
Schwann cells	8085
The cell transplant group	8100
injections of about 30,000 cells/μl	8135
injections	8135
30,000 cells/μl	8155
Experimental Protocol	8187
Four to five weeks	8210
transection of the dorsal columns	8235
transection	8235
the dorsal columns	8250
the spinal cords	8270
electrophysiological analysis	8314
a recording chamber -LRB- see Experimental Protocol -RRB-	8347
a recording chamber	8347
Experimental Protocol	8372
The completeness of the lesion	8396
The completeness	8396
the lesion	8416
anatomical techniques	8459
only those spinal cords	8486
histologically complete transections of their dorsal columns	8544
histologically complete transections	8544
their dorsal columns	8584
analysis	8619
The surface of the dorsal columns	8629
The surface	8629
the dorsal columns	8644
a silver wire electrode caudal	8683
the transection site	8717
afferent sensory axons	8760
dorsal root ganglia	8800
they	8823
the fasciculus gracilis of the dorsal columns	8843
the fasciculus gracilis	8843
the dorsal columns	8870
Glass microelectrodes	8890
field potentials	8932
the propagating action potentials	8952
the midline surface of the dorsal columns -LRB- Fig. 2A -RRB-	8991
the midline surface	8991
the dorsal columns -LRB- Fig. 2A -RRB-	9014
the dorsal columns	9014
Fig. 2A	9034
Virtually no electrical activity	9044
the lesion site in histologically complete non-transplanted rats	9102
the lesion site	9102
histologically complete non-transplanted rats	9121
a lack of regeneration	9178
a lack	9178
regeneration	9188
the lesion site -LRB- Fig. 2B ; n = 9 -RRB-	9208
the lesion site	9208
Fig. 2B ; n = 9	9225
Fig. 2B	9225
n = 9	9234
n	9234
9	9238
Only a stimulus artifact with no electrophysiological response	9242
Only a stimulus artifact	9242
no electrophysiological response	9272
a recording obtained across a lesion site with no cell transplantation	9324
a recording	9324
a lesion site	9352
no cell transplantation	9371
transgenic pig OECs	9410
the transection site	9453
compound action potentials	9475
the site of transection -LRB- Fig. 2C -RRB-	9530
the site	9530
transection -LRB- Fig. 2C -RRB-	9542
transection	9542
Fig. 2C	9555
7 of 10 rats indicating axonal regeneration through the lesion site	9567
7	9567
10 rats indicating axonal regeneration through the lesion site	9572
10 rats	9572
axonal regeneration	9591
the lesion site	9619
5 mm beyond the lesion site compound	9639
5 mm	9639
the lesion site compound	9651
action potentials	9676
the transplant groups	9724
amplitude	9770
non-transected control spinal cords	9797
non-transected control	9797
spinal cords	9820
Conduction	9834
the transection site	9865
both transgenic pig OEC and Schwann cells transplantation	9890
Conduction velocity	9949
the inverse slope of a plot of latency versus distance for several points	9989
the inverse slope	9989
a plot of latency versus distance for several points	10010
a plot	10010
latency versus distance for several points	10020
latency	10020
distance for several points	10035
distance	10035
several points	10048
the lesion	10070
Figure 3A	10082
conduction velocities	10098
control	10124
transection alone	10133
following transplantation of either OECs or Schwann cells	10155
following transplantation	10155
either OECs or Schwann cells	10184
OECs	10191
Schwann cells	10199
Virtually no conduction	10214
transection	10261
conduction velocity	10295
the regenerated axons	10331
OEC -LRB- 20.98 ± 5.38 m/sec ; n = 7 ; P = 0.002 -RRB-	10363
OEC	10363
20.98 ± 5.38 m/sec ; n = 7 ; P = 0.002	10368
20.98 ± 5.38 m/sec	10368
20.98	10368
5.38 m/sec	10376
n = 7	10388
n	10388
7	10392
P = 0.002	10395
P	10395
0.002	10399
Schwann cells -LRB- 19.09 ± 6.2 m/sec ; n = 5 ; P = 0.033 -RRB-	10409
Schwann cells	10409
19.09 ± 6.2 m/sec ; n = 5 ; P = 0.033	10424
19.09 ± 6.2 m/sec	10424
19.09 ±	10424
6.2 m/sec	10432
n = 5	10443
n	10443
5	10447
P = 0.033	10450
P	10450
0.033	10454
transplantation	10461
control uninjured spinal cords -LRB- 12.93 ± 2.06 m/sec ; n = 11 -RRB-	10494
control uninjured spinal cords	10494
control	10494
12.93 ± 2.06 m/sec ; n = 11	10526
12.93 ± 2.06 m/sec ; n	10526
12.93 ± 2.06 m/sec	10526
12.93	10526
2.06 m/sec	10534
n	10546
= 11	10548
There	10555
no difference	10565
conduction velocity between OEC	10582
conduction velocity	10582
OEC	10610
Schwann cells transplanted groups -LRB- P = 0.28 -RRB-	10618
Schwann cells	10618
transplanted groups -LRB- P = 0.28 -RRB-	10632
transplanted groups	10632
P	10653
0.28	10657
The rapid conduction velocities in the transplanted spinal cords	10664
The rapid conduction velocities	10664
the transplanted spinal cords	10699
the axons	10743
histological analysis	10785
Recognizable	10808
compound action potentials	10837
at least 14 mm -LRB- length of recording chamber -RRB-	10882
at least 14 mm	10882
length of recording chamber	10898
length	10898
recording chamber	10908
the transection site in both OEC and Schwann cells	10934
the transection site	10934
both OEC and Schwann cells	10958
OEC	10963
Schwann cells	10971
dorsal columns	10998
Plots	11014
compound action potentialsamplitude	11023
a percent of the first wave versus distance beyond the lesion site	11062
a percent	11062
the first wave versus distance beyond the lesion site	11075
the first wave	11075
distance beyond the lesion site	11097
distance	11097
the lesion site	11113
control , OEC and Schwann cells transplantation in Figure 3B	11143
control , OEC and Schwann cells transplantation	11143
Figure 3B	11193
Control and transplant groups	11204
attenuation of the responses	11241
attenuation	11241
the responses	11256
increasing conduction distance	11275
The attenuation	11307
the result of temporal and spatial dispersion of the axons	11335
the result	11335
temporal and spatial dispersion	11349
the axons	11384
Both OEC and Schwann cells transplant groups	11395
Both OEC and Schwann cells	11395
transplant groups	11422
less relative attenuation	11450
distance particularly more	11481
distance	11481
the first several millimeters of conduction	11513
the first several millimeters	11513
conduction	11546
controls	11574
We	11584
this	11613
the geometric complexity of lesioned cord at and near the lesion site	11638
the geometric complexity	11638
lesioned cord at and near the lesion site	11666
lesioned cord	11666
the lesion site	11692
the axons	11709
a tortuous trajectory	11728
this region , which is reflected as greater stability of the response amplitude	11753
this region	11753
greater stability of the response amplitude	11788
greater stability	11788
the response amplitude	11809
These results	11833
axonal regeneration as assayed	11861
axonal regeneration as	11861
a significant longitudinal distance within the spinal cord	11928
a significant longitudinal distance	11928
the spinal cord	11971
Axonal signaling	11988
the discharge of several action potentials	12030
the discharge	12030
several action potentials	12047
the regenerated axons	12090
high frequency discharge	12126
we	12151
their frequency-response properties	12163
Figure 3C	12200
the attenuation	12216
the compound action potential	12235
increasing stimulus frequency for control , OEC and Schwann cells	12270
increasing stimulus frequency	12270
control , OEC and Schwann cells	12304
transplant groups	12335
5 mm	12362
the lesion site	12374
frequencies up to 400 Hz	12394
frequencies	12394
400 Hz	12412
there	12419
no difference	12429
the intact control	12451
transplant groups	12474
the regenerated axons	12508
stable high frequency discharge properties	12539
normal axons	12593
paired pulse experiments	12617
the refractory properties of the axons	12657
the refractory properties	12657
the axons	12686
all groups -LRB- Fig. 3D -RRB-	12713
all groups	12713
Fig. 3D	12725
Localization	12735
donor cells and morphology of regenerated axons	12759
donor cells and morphology	12759
regenerated axons	12789
A limited number of spinal cords	12807
A limited number	12807
spinal cords	12827
transplants	12849
fluorescently labeled donor cells	12864
Experimental Protocol	12903
their survival and presence	12941
the host	12972
Confocal imaging of 5 - -LRB- and -6 -RRB-	12982
Confocal imaging	12982
5	13002
and -6	13005
carboxyfluoresceine diacetate	13013
succinimidyl ester	13044
CFDA	13064
SE	13070
loaded transplanted OECs -LRB- Fig. 4 -RRB-	13074
loaded transplanted OECs	13074
Fig. 4	13100
Schwann cells -LRB- not shown -RRB-	13112
Schwann cells	13112
transplanted myelin-forming cells	13156
the dorsal column region for at least 4 weeks	13206
the dorsal column region	13206
at least 4 weeks	13235
transplantation	13258
several millimeters	13287
the rostral-caudal axis of the spinal cord	13313
the rostral-caudal axis	13313
the spinal cord	13340
It	13357
we	13386
the donor cells	13398
the margins of the transected cord both rostrally	13419
the margins	13419
the transected cord both rostrally	13434
the	13434
cord	13449
the gap of the lesion	13496
the gap	13496
the lesion	13507
The demonstration	13519
viable transplanted cells	13542
the spinal cord spanning the lesion gap	13584
the spinal cord	13584
the lesion gap	13609
a ` bridge ' of donor cells	13639
a ` bridge '	13639
donor cells	13653
the in vitro electrophysiological studies the spinal cords	13700
the in vitro electrophysiological studies	13700
electrophysiological studies	13713
the spinal cords	13742
histological analysis	13788
standard plastic embedding protocols	13816
Experimental Protocol	13858
Histological examination of semi-thin sections	13882
Histological examination	13882
semi-thin sections	13910
the surgical protocol	13944
a complete transection of the dorsal columns	13988
a complete transection	13988
the dorsal columns	14014
minimal damage	14038
the ventral horns	14056
The dorsal columns in all lesioned animals used in this study	14075
The dorsal columns	14075
all lesioned animals used in this study	14097
all lesioned animals	14097
this study	14126
Histological examination	14165
transected dorsal columns with transplanted transgenic pig OECs or Schwann cells	14193
transected dorsal columns	14193
transplanted transgenic pig OECs or Schwann cells	14224
transplanted transgenic pig OECs	14224
Schwann cells	14260
dispersed axons	14283
Schwann cell-like patterns	14310
myelination	14340
large cytoplasmic and nuclear regions and the presence of a basement membrane	14353
large cytoplasmic and nuclear regions and the presence	14353
large cytoplasmic and nuclear regions	14353
the presence	14395
a basement membrane	14411
within and rostral	14437
within	14437
rostral	14448
the transection sites	14459
The electron micrographs in Figure 5	14482
The electron micrographs	14482
Figure 5	14510
the presence	14531
a peripheral pattern	14547
myelination for both transgenic pig OEC and Schwann cell transplantation	14571
myelination	14571
both transgenic pig OEC and Schwann cell transplantation	14587
The patterns of axonal distribution	14645
The patterns	14645
axonal distribution	14661
slightly different between OEC and Schwann cell transplantation	14686
OEC and Schwann	14713
axons in OEC transplanted lesions	14762
axons	14762
OEC transplanted lesions	14771
small bundles of 3	14824
small bundles	14824
3	14841
8 axons with a large surrounding extracellular space -LRB- Fig. 5A -RRB-	14843
8 axons	14843
a large surrounding extracellular space -LRB- Fig. 5A -RRB-	14856
a large surrounding extracellular space	14856
Fig. 5A	14897
myelinated axonal profiles in Schwann	14915
myelinated axonal profiles	14915
Schwann	14945
cell transplanted lesions seemed to be more random	14953
cell	14953
transplanted lesions	14958
Fig. 5B	15005
Electron microscopic analysis of the spinal cords	15015
Electron microscopic analysis	15015
the spinal cords	15048
both OEC and SC	15080
OEC	15085
SC	15093
transplanted spinal cords	15096
relatively thick myelin surrounded by a basement membrane	15134
relatively thick myelin	15134
a basement membrane	15172
Fig. 5C -- D	15193
Fig. 5C	15193
D	15201
Consistent	15205
the electrophysiological evidence	15221
myelinated axons	15258
dorsal column lesions	15303
semi-thin plastic-embedded sections of lesioned dorsal columns	15326
semi-thin plastic-embedded sections	15326
lesioned dorsal columns	15365
Experimental Protocol	15394
the presence	15426
many axons	15442
the characteristic appearance of peripherally myelinated axons	15461
the characteristic appearance	15461
peripherally myelinated axons	15494
adjacent to OEC or Schwann cell transplanted lesions	15535
OEC or Schwann cell	15547
Counts of myelinated axons	15589
Counts	15589
myelinated axons	15599
the lesion	15639
an increase	15659
the numbers of myelinated axons	15674
the numbers	15674
myelinated axons	15689
the transection site	15723
animals receiving transplants of transgenic pig OECs or Schwann cells	15747
animals	15747
transplants of transgenic pig OECs or Schwann cells	15765
transplants	15765
transgenic pig OECs or Schwann cells	15780
Lesions transplanted with pig OECs or Schwann cells	15818
Lesions	15818
pig OECs or Schwann cells	15844
an average of 304 ± 56 -LRB- n = 10 -RRB- and 268 ± 61 -LRB- n = 4 -RRB-	15880
an average of 304 ± 56 -LRB- n = 10 -RRB- and 268 ± 61	15880
an average of 304 ± 56 -LRB- n = 10 -RRB-	15880
an average	15880
304 ± 56 -LRB- n = 10 -RRB-	15894
304 ± 56	15894
n	15904
10	15908
268 ± 61	15916
268	15916
61	15922
n	15926
4	15930
peripheral-like myelinated axons	15948
the lesion compared with only 112 ± 22 -LRB- n = 9 -RRB-	15990
the lesion	15990
only 112 ± 22	16015
only 112	16015
22	16026
n	16030
9	16034
axons in control lesions	16037
axons	16037
control lesions	16046
Numbers	16063
myelinated axons	16074
the lesion in OEC and Schwann cell transplanted lesions combined	16108
the lesion in OEC	16108
the lesion	16108
OEC	16122
Schwann cell transplanted lesions combined	16130
Schwann cell transplanted lesions	16130
control lesions at P	16201
control lesions	16201
P	16220
0.003 , respectively -LRB- unpaired two tailed Student 's t test -RRB-	16224
0.003 , respectively	16224
0.003	16224
unpaired two tailed Student 's t test	16245
unpaired two	16245
Student 's t test	16265
Student 's	16265
Discussion Transplantation of allogeneic OECs	16285
Discussion Transplantation	16285
allogeneic OECs	16315
refs	16332
9 and 11 -RRB- or Schwann cells	16338
9 and 11 -RRB-	16338
9	16338
11	16344
Schwann cells	16351
refs	16366
8 and 12 -RRB-	16372
8	16372
12	16378
demyelinated axons	16413
axonal regeneration of transected axons	16454
axonal regeneration	16454
transected axons	16477
the rat spinal cord3	16497
,5,13,14	16517
A recent study	16527
transplantation or human OECs	16557
transplantation	16557
human OECs	16576
the immunosuppressed rat spinal cord15	16603
the feasibility of xenotransplantation	16658
the feasibility	16658
xenotransplantation	16677
axons	16707
Electrophysiological and histological examination	16714
transected dorsal columns in this study	16767
transected dorsal columns	16767
this study	16796
the conclusion	16815
transplantation of either transgenic pig OECs or Schwann cells	16835
transplantation	16835
either transgenic pig OECs or Schwann cells	16854
transgenic pig OECs	16861
Schwann cells	16884
long distance regeneration of functionally remyelinated axons	16909
long distance regeneration	16909
functionally remyelinated axons	16939
the spinal cord	16978
Compound action potentials	16995
14 mm -LRB- recording chamber length -RRB- rostral	17046
14 mm -LRB- recording chamber length -RRB-	17046
14 mm	17046
recording chamber length	17053
histologically complete dorsal column transections	17090
cell transplants	17159
The conduction velocity	17177
frequency-response characteristics of the regenerated axons crossing the lesion	17205
frequency-response characteristics	17205
the regenerated axons crossing the lesion	17243
the regenerated axons	17243
the lesion	17274
myelinated axons	17304
histological sections	17326
numerous Schwann	17357
peripheral pattern	17385
the dorsal column area rostral	17437
the lesion of the rostrally projecting sensory axons	17471
the lesion	17471
the rostrally projecting sensory axons	17485
lesioned controls -LRB- no transplant -RRB-	17528
lesioned controls	17528
no transplant	17547
virtually no conduction	17562
the transection site	17606
The conduction	17628
the lesion site	17650
transplanted recipients	17669
the absence of conduction in non-transplanted animals	17697
the absence	17697
conduction in non-transplanted animals	17712
conduction	17712
non-transplanted animals	17726
experiments using rat donor cells4	17766
experiments	17766
rat donor cells4	17784
This	17802
cross-species transplantation of genetically altered cells	17822
cross-species transplantation	17822
genetically altered cells	17855
the repair potential of the cells in immunosuppressed rats	17897
the repair potential	17897
the cells in immunosuppressed rats	17921
the cells	17921
immunosuppressed rats	17934
the electrophysiological data	17966
functionally remyelinated axons	18017
it	18050
the CAPs of both OEC and Schwann cell-induced regenerated axons	18072
the CAPs	18072
both OEC and Schwann cell-induced regenerated axons	18084
both OEC and Schwann	18084
cell-induced regenerated axons	18105
conduction velocities greater	18140
conduction velocities	18140
control	18175
axons	18203
regenerated axons	18210
repetitive stimuli	18253
frequencies up to 200 Hz	18275
frequencies	18275
200 Hz	18293
these results	18316
a rapid and secure conduction pathway	18344
transplantation of either transgenic pig OECs or Schwann cells	18402
transplantation	18402
either transgenic pig OECs or Schwann cells	18421
transgenic pig OECs	18428
Schwann cells	18451
the transected dorsal column lesion	18470
the	18470
dorsal column lesion	18485
Electron microscopic analysis	18507
both OECs and Schwann cells	18552
OECs	18557
Schwann cells	18566
a peripheral-type of myelination pattern	18590
a peripheral-type	18590
myelination pattern	18611
large cytoplasmic and nuclear components surrounding the myelin	18636
large cytoplasmic and nuclear components	18636
the myelin	18689
the presence of a basal lamina , which are characteristic of peripheral myelin16	18705
the presence	18705
a basal lamina , which are characteristic	18721
a basal lamina	18721
peripheral myelin16	18765
extracellular collagen deposition	18796
peripheral myelin	18858
cells	18884
the spinal cord	18907
The myelinated axons following OEC transplantation	18924
The myelinated axons	18924
OEC transplantation	18955
bundles	18996
myelinated axons	19013
Schwann cell transplantation	19060
Li et al. 3	19090
Li	19090
et al. 3	19093
et al.	19093
3	19099
a similar bundling	19108
myelinated axons	19130
transplantation of OECs in a electrolytic corticospinal lesion site	19157
transplantation	19157
OECs in a electrolytic corticospinal lesion site	19176
OECs	19176
a electrolytic corticospinal lesion site	19184
The bundling	19226
regenerated myelinated axons that was typical in the OEC transplants	19242
regenerated myelinated axons	19242
the OEC transplants	19291
there	19325
some differences	19338
the pattern	19358
axonal regeneration following transplantation of OECs versus Schwann cells	19373
axonal regeneration	19373
transplantation of OECs versus Schwann cells	19403
transplantation	19403
OECs versus Schwann cells	19422
OECs	19422
Schwann cells	19434
spite of these anatomical differences	19452
spite	19452
these anatomical differences	19461
we	19491
no difference	19500
the electrophysiological properties	19517
transgenic pig OEC or Schwann cell transplantation	19563
transgenic pig OEC	19563
Schwann cell transplantation	19585
Histological examination of the spinal cords 4 -- 5 weeks after injection	19615
Histological examination	19615
the spinal cords 4 -- 5 weeks after injection	19643
the spinal cords 4	19643
the spinal cords	19643
4	19660
5 weeks after injection	19662
5 weeks	19662
injection	19676
the spinal cord	19701
axons and transplanted cells	19754
axons	19754
transplanted cells	19764
the transition zone	19799
The injury site	19831
normal oligodendrocytemyelinated axons	19866
regenerated axons that exhibited a peripheral pattern of myelination	19929
regenerated axons	19929
a peripheral pattern of myelination	19962
a peripheral pattern	19962
myelination	19986
The dorsal columns	19999
several cuts	20048
sparing of residual intact axons within the lesion zone	20065
sparing	20065
residual intact axons within the lesion zone	20076
residual intact axons	20076
the lesion zone	20105
One proposal	20152
the fusion of the cut spinal cord	20176
the fusion	20176
the cut spinal cord	20190
the severe injury	20216
the OECs and Schwann cells	20242
the lesion zone	20292
guide cells for the axons	20322
guide cells	20322
the axons	20338
extent	20351
the lesion	20365
a hospitable regenerative environment	20389
These cells	20428
inhibitory proteins that induce growth cone collapse as do oligodendrocytes	20455
inhibitory proteins	20455
growth cone collapse as do oligodendrocytes	20487
growth cone collapse	20487
oligodendrocytes	20514
CNS axons	20532
peripheral nerve grafts17	20565
an environment	20598
glial inhibitory proteins	20619
antibodies18	20670
The transplanted OECs and Schwann cells	20684
The transplanted OECs	20684
Schwann cells	20710
trophic support	20743
axonal regeneration	20772
both OECs -LRB- ref .19 -RRB- and Schwann cells -LRB- ref	20793
OECs -LRB- ref .19 -RRB-	20798
OECs	20798
ref .19	20804
Schwann cells -LRB- ref	20816
Schwann cells	20816
ref	20831
20 -RRB- can express NGF P75 receptors and Schwann cells	20836
20 -RRB-	20836
NGF P75 receptors and Schwann cells	20852
NGF -LRB- ref	20909
NGF	20909
ref	20914
21	20919
axotomy	20929
It	20938
NGF and NGF receptor interactions or other neurotrophins	20973
NGF and NGF receptor interactions	20973
other neurotrophins	21010
the enhanced regenerative capacity	21044
CNS axons after OEC and Schwann cell transplantation	21082
CNS axons	21082
OEC and Schwann cell transplantation	21098
The demonstration	21136
OECs and SCs derived from hCD59 transgenic pigs	21159
OECs and SCs	21159
hCD59 transgenic pigs	21185
axonal regeneration of functionally intact axons	21218
axonal regeneration	21218
functionally intact axons	21241
the potential	21278
cell therapy approaches	21295
engineered xenogeneic cells	21325
damaged CNS axonal tracts	21363
Contusive spinal cord injury	21390
transection of axons	21439
transection	21439
axons	21454
demyelination of long tracts	21484
demyelination	21484
long tracts	21501
addition to demyelination	21527
addition	21527
demyelination	21539
axonal transection	21554
early several sclerosis lesions 22	21592
early several sclerosis lesions	21592
22	21624
Engineered pig OECs and Schwann cells	21628
the hCD59 gene	21690
at least some degree of axonal regeneration and form	21719
at least some degree	21719
axonal regeneration and form	21743
These cells	21780
large numbers	21822
a donor cell for cell therapy	21858
a donor cell	21858
cell therapy	21875
the demyelinated or injured spinal cord	21909
the	21909
spinal cord	21937
there	21961
several clinical applications for the use of porcine tissues	21971
several clinical applications	21971
the use of porcine tissues	22005
the use	22005
porcine tissues	22016
example	22037
the treatment	22046
Parkinson 's disease patients	22063
Parkinson 's	22063
fetal porcine neural cells1 ,23	22097
fetal porcine neural cells1	22097
,23	22124
the use	22131
porcine hepatocytes for liver support systems in cases of acute liver failure1	22142
porcine hepatocytes	22142
liver support systems in cases of acute liver failure1	22166
liver support systems	22166
cases of acute liver failure1	22191
cases	22191
acute liver failure1	22200
,24	22220
the success of these applications	22234
the success	22234
these applications	22249
the poor understanding	22288
the mechanisms	22314
many cases	22342
loss of function and rejection of the transplanted tissue	22356
loss	22356
function and rejection	22364
the transplanted tissue	22390
Many porcine cell types	22415
Many porcine	22415
cell types	22428
transplantation	22450
cardiomyocytes25 or OECs -LRB- refs	22475
cardiomyocytes25	22475
OECs -LRB- refs	22495
9 and 11 -RRB- and Schwann cells	22507
9 and 11 -RRB-	22507
9	22507
11	22513
Schwann cells	22521
ref	22536
spinal cord repair	22548
a humoral and cellular immune response2	22597
the demonstration	22648
genetically modified OECs and Schwann cells	22671
genetically modified OECs	22671
Schwann cells	22701
allotransplants4	22737
these engineered cells	22763
humoral immunity	22815
the use of transgenic porcine tissues for human therapy	22842
the use	22842
transgenic porcine tissues for human therapy	22853
transgenic porcine tissues	22853
human therapy	22884
transgenic porcine cells	22908
several advantages	22938
human fetal tissue	22962
availability	22990
quality control	23004
the tissues obtained and timing of cell collection and reproducibility	23023
the tissues obtained	23023
the tissues	23023
timing of cell collection and reproducibility	23048
timing	23048
cell collection and reproducibility	23058
Experimental protocol Cell preparation and culture	23096
The anterior tips of the olfactory bulbs	23147
The anterior tips	23147
the olfactory bulbs	23168
the sciatic nerves of transgenic pigs	23192
the sciatic nerves	23192
transgenic pigs	23214
1-mm pieces	23256
Sciatic nerve pieces	23269
90 min -LRB- 30 -- 40 min for OEC collections -RRB- at 37 °C in DMEM	23314
90 min -LRB- 30 -- 40 min for OEC collections -RRB-	23314
30	23322
40 min for OEC collections	23325
40 min	23325
OEC collections	23336
37 °C in DMEM	23356
37 °C	23356
DMEM	23364
1 mg/ml each of collagenase A and D ; Boheringer Mannheim -RRB-	23374
1 mg/ml	23374
each	23382
collagenase A and D ; Boheringer Mannheim	23390
collagenase A and D	23390
Boheringer Mannheim	23411
continuous agitation	23437
The resulting mixture	23459
cells	23506
2.5 mg/ml trypsin -LRB- Boehringer Manheim , Germany -RRB-	23535
2.5 mg/ml trypsin	23535
Boehringer Manheim	23554
Germany	23574
0.5 mg/ml DNAse for 15 -- 30 min -LRB- 10 min	23587
0.5 mg/ml DNAse for 15	23587
0.5 mg/ml DNAse	23587
15	23606
30 min -LRB- 10 min	23609
30 min	23609
10 min	23617
10	23617
min	23620
OEC collections	23629
OEC	23629
collections	23633
Cell suspensions	23647
Dulbecco 's modified Eagle 's medium -LRB- DMEM -RRB- with 10 % fetal calf	23705
Dulbecco 's	23705
Eagle 's medium -LRB- DMEM -RRB-	23725
Eagle 's medium	23725
Eagle 's	23725
DMEM	23741
10 %	23752
serum	23767
a flame polished siliconized pipette	23796
a flame polished	23796
pipette	23825
Any large undissociated pieces of tissue	23834
Any large undissociated pieces	23834
tissue	23868
cells	23908
DMEM and resuspending	23925
a concentration of 30,000 cells/μl in DMEM for transplantation	23950
a concentration	23950
30,000 cells/μl in DMEM for transplantation	23969
30,000 cells/μl	23969
DMEM for transplantation	23988
DMEM	23988
transplantation	23997
Enzymatic activity	24014
10 % fetal calf serum	24050
medium	24082
the cells	24093
DMEM	24124
them	24149
30,000 cells/μl in DMEM	24157
30,000 cells/μl	24157
DMEM	24176
Transgenic expression analysis Schwann cell	24182
OECs isolated from hCD59 transgenic animals	24230
OECs	24230
hCD59 transgenic animals	24249
expression	24291
the transgene	24305
indirect immunofluorescence	24322
the anti-hCD59 mouse monoclonal antibody	24356
mAb	24398
MEM-43 -LRB- Biodesign International , Kennebunkport , ME -RRB-	24404
MEM-43	24404
Biodesign International	24412
Kennebunkport	24437
ME	24452
a polyclonal anti-hCD59 antibody , ALP-3	24461
a polyclonal anti-hCD59 antibody	24461
ALP-3	24495
26 -RRB- .	24507
Endogenous expression of SLA class	24512
Endogenous expression	24512
SLA class	24537
I	24547
the anti-SLA Class I mAb , PT85A -LRB- VARD , Inc. , Pullman , WA -RRB-	24566
the anti-SLA Class I mAb	24566
the anti-SLA Class	24566
I mAb	24585
PT85A -LRB- VARD , Inc. , Pullman , WA -RRB-	24592
PT85A	24592
VARD	24599
Inc.	24605
Pullman , WA	24611
a positive control antibody	24638
Indirect immunofluorescence	24667
1 ×	24722
104 to 1	24726
× 105 cells	24735
20 μg/ml of the polyclonal	24752
20 μg/ml	24752
the polyclonal	24764
10 μg/ml of MEM 43 in 1 ×	24787
10 μg/ml	24787
MEM 43 in 1 ×	24799
MEM 43	24799
1 ×	24809
PBS	24812
2 % fetal bovine serum	24821
Goat anti-rabbit IgG	24844
polyclonal sera , Zymed , South San Francisco , CA	24866
polyclonal sera	24866
Zymed	24883
South San Francisco	24890
CA	24911
goat anti-mouse IgG -LRB- monoclonal sera , Zymed -RRB-	24918
goat anti-mouse IgG	24918
monoclonal sera , Zymed	24939
monoclonal sera	24939
fluorescein isothiocyanate	24963
FITC	24991
antisera	25009
specific antibody binding	25038
the cell surface	25067
Cell surface expression	25085
flow cytometry on a Becton-Dickinson FACSort	25130
flow cytometry	25130
a Becton-Dickinson FACSort	25148
Surgical procedures Adult Wistar rats	25176
Surgical procedures	25176
Adult Wistar rats	25196
ketamine/xylazine -LRB- 75 mg/kg ; 10 mg/kg , i.p. -RRB-	25244
ketamine/xylazine	25244
75 mg/kg ; 10 mg/kg , i.p.	25263
75 mg/kg	25263
10 mg/kg , i.p.	25273
10 mg/kg	25273
a standard lumbar spinal cord dorsal column transection at vertebral level T11	25306
a standard lumbar spinal cord dorsal column transection	25306
vertebral level T11	25365
A sterile laminectomy	25386
T11 and dorsal column	25425
several transverse cuts	25465
a pair	25494
8.5 cm Vannas-Tubbinegin spring scissors	25504
Fine Science Tools , Forest City California	25546
Fine Science Tools	25546
Forest City California	25566
the top of the spinal cord	25596
the top	25596
the spinal cord	25607
the central vein	25636
This surgery	25654
paraparesis of the hind limbs	25679
paraparesis	25679
the hind limbs	25694
all animal subjected to the procedure	25712
all animal	25712
the procedure	25736
locomotion	25771
eating , drinking or elimination	25792
spinal cord transection , 1.0 ml of freshly isolated transgenic pig OECs	25843
spinal cord transection	25843
1.0 ml of freshly isolated transgenic pig OECs	25868
1.0 ml	25868
freshly isolated transgenic pig OECs	25878
Schwann cells or control DMEM -LRB- Gibco BRG -RRB-	25916
Schwann cells	25916
control DMEM -LRB- Gibco BRG -RRB-	25933
control DMEM	25933
Gibco BRG	25947
the dorsal column	25977
a drawn glass micropipette	25999
depths of 0.5	26029
depths	26029
0.5	26039
0.7 mm at two injection sites 0.5 mm rostral and caudal to the lesion	26047
0.7 mm	26047
two injection sites 0.5 mm rostral and caudal to the lesion	26057
two injection sites 0.5 mm rostral	26057
two injection sites	26057
0.5 mm rostral	26077
caudal to the lesion	26096
caudal	26096
the lesion	26106
OECs and Schwann cells	26118
a concentration	26158
30,000 cells/μl for a total of 60,000 cells transplanted into each animal	26177
30,000 cells/μl	26177
a total of 60,000 cells transplanted into each animal	26197
a total	26197
60,000 cells transplanted into each animal	26208
60,000 cells	26208
each animal	26239
Electrophysiological analysis of axonal conduction	26252
Electrophysiological analysis	26252
axonal conduction	26285
Four to five weeks	26303
spinal cord transection and cell transplantation	26328
rats	26378
sodium pentobarbital anesthesia	26401
75 mg/kg	26434
The vertebral column from each animal between T5 and L2	26450
The vertebral column	26450
each animal between T5 and L2	26476
each animal	26476
T5 and L2	26496
cold dissecting solution	26553
135 mM choline chloride	26579
20 mM choline bicarbonate/1 .0 mM KCl ; 1.2 mM KH2PO4 ; 90 mM dextrose	26604
20 mM choline bicarbonate/1 .0 mM KCl	26604
20 mM choline	26604
bicarbonate/1 .0 mM KCl	26618
1.2 mM KH2PO4	26642
1.2 mM	26642
KH2PO4	26649
90 mM dextrose	26657
90 mM	26657
dextrose	26663
The spinal cord region between T6 and L1	26674
The spinal cord region	26674
T6 and L1	26705
a recording chamber	26741
zero calcium	26788
Krebs ' solution	26810
Krebs '	26810
124 mM NaCl	26827
3mM KCl	26840
2.0 mM MgCl2	26849
26 mM NaHCO3	26863
1.3 NaHPO4	26877
10 mM dextrose	26889
95 % O2/5 % CO2	26920
95 %	26920
O2/5 %	26924
a drip rate of 4.0	26936
a drip rate	26936
4.0	26951
5.5 ml/min at room temperature for 30 min	26955
5.5 ml/min	26955
room temperature for 30 min	26969
room temperature	26969
30 min	26990
CaCl2 -LRB- 2.0 mM -RRB-	26998
CaCl2	26998
2.0 mM	27005
the solution	27031
electrophysiological recordings	27045
2 h	27091
36 °C	27104
The site of the spinal cord transection	27110
The site	27110
the spinal cord transection	27122
the presence	27168
a pale yellow scar	27184
the dorsal surface of the spinal cord	27231
the dorsal surface	27231
the spinal cord	27253
A bipolar silver stimulating electrode	27270
A bipolar silver	27270
electrode	27299
the dorsal column 1 mm caudal to the transection site	27327
the dorsal column 1 mm caudal	27327
the transection site	27360
Electrical responses	27382
glass micro-electrodes	27422
2M NaC1 -LRB- 3 -- 10 MΩ resistance -RRB-	27457
2M NaC1	27457
3 -- 10 MΩ resistance	27466
3	27466
10 MΩ resistance	27469
the surface of the dorsal column at successive points	27492
the surface	27492
the dorsal column at successive points	27507
the dorsal column	27507
successive points	27528
1 to 15 mm rostral to the lesion site	27551
1 to 15 mm rostral	27551
the lesion site	27573
Stimulus intensity	27590
25 %	27620
the strength necessary to elicit maximal compound action potentials amplitude	27630
the strength	27630
maximal compound action potentials amplitude	27663
Donor cell labeling	27709
some experiments	27733
cells	27751
CFDA , SE -LRB- Molecular Probes , Eugene , OR -RRB-	27774
CFDA	27774
SE -LRB- Molecular Probes , Eugene , OR -RRB-	27780
SE	27780
Molecular Probes	27784
Eugene	27802
OR	27810
transplantation	27821
their location	27849
the time of killing	27867
the time	27867
killing	27879
cells or OECs	27908
20	27942
μM CFDA , SE for 15 min -LRB- ref	27945
μM CFDA	27945
SE for 15 min -LRB- ref	27954
SE for 15	27954
SE	27954
15	27961
min -LRB- ref	27964
27 -RRB- and washed 3 times with DMEM before transplantation .	27974
27	27974
3 times with DMEM	27989
3 times	27989
DMEM	28002
transplantation	28014
CFDA , SE loaded cells that were cultured for 2 --	28031
CFDA	28031
SE loaded cells	28037
SE	28037
loaded cells	28040
2	28076
4 weeks	28078
no evidence of dye toxicity and confirmed that the dye	28093
no evidence	28093
toxicity	28112
the	28140
Schwann cells and OECs	28164
the culture period	28198
Dye	28218
sensory neurons	28255
CFDA , SE loaded cells	28276
CFDA	28276
SE loaded cells	28282
SE	28282
loaded cells	28285
cultures of rat DRG neurons	28312
cultures	28312
rat DRG neurons	28324
Histology Following electrophysiological recordings , spinal cord tissue	28341
Histology	28341
electrophysiological recordings , spinal cord tissue	28361
electrophysiological recordings	28361
spinal cord tissue	28394
24 h	28427
2 % paraformaldehyde	28435
2 % glutaraldehyde -LRB- weight/volume in 0.14 M Sorensen 's buffer -RRB-	28460
2 % glutaraldehyde	28460
weight/volume in 0.14 M Sorensen 's buffer	28479
weight/volume	28479
0.14 M Sorensen 's buffer	28496
0.14 M	28496
Sorensen 's buffer	28503
Sorensen 's	28503
routine histological analysis	28526
4 % paraformaldehyde for confocal fluorescence microscopy	28560
4 % paraformaldehyde	28560
confocal fluorescence microscopy	28584
Tissue intended for routine histology	28618
Tissue	28618
routine histology	28638
3 times	28667
overnight in buffer	28683
overnight	28683
buffer	28696
2-mm segments	28716
Spinal cord segments	28731
1 % osmium -LRB- Polysciences , Warrington PA -RRB-	28778
1 % osmium	28778
Polysciences	28789
Warrington PA	28803
4 h	28822
Epox-812 -LRB- Ernest Fullam Inc. , Latham , NY -RRB-	28842
Epox-812	28842
Ernest Fullam Inc.	28852
Latham	28872
NY	28880
Tissue	28885
an ultramicrotome	28923
1-μm sections	28945
every 0.25 mm	28974
Sections	28989
0.5 % methylene blue , 0.5 % azure II	29028
0.5 % methylene blue	29028
0.5 % azure II	29049
0.5 % azure	29049
II	29060
0.5 % borax	29066
Spinal cords examined with confocal microscopy	29078
Spinal cords	29078
confocal microscopy	29105
PBS buffer	29145
1-cm lengths that were notched to indicate rostral/caudal orientation	29166
1-cm lengths	29166
rostral/caudal orientation	29209
three approximately equal longitudinal sections	29258
